“Increasing Shift toward Point-Of-Care Testing (POCT)”
The global ferritin testing market is expanding rapidly due to the increasing awareness of iron deficiency disorders and advancements in diagnostic technologies. One notable trend is the shift toward point-of-care testing (POCT), which enables quick and convenient ferritin testing outside of traditional laboratory settings. This trend is gaining traction, especially in regions with limited access to healthcare infrastructure. For instance, Abbott has developed portable ferritin testing devices that provide accurate results in real-time, making it easier for healthcare providers to diagnose iron deficiency and related conditions. In addition, the rising incidence of iron deficiency anemia and its associated health complications, particularly in aging populations, is fueling demand for ferritin tests. In North America, where iron deficiency is a significant health concern, the market is growing rapidly, with an increasing number of hospitals and diagnostic laboratories adopting advanced ferritin testing solutions. As a result, the global ferritin testing market is poised for continued growth, driven by technological innovations and rising healthcare awareness.
